Harvard Bioscience, Inc. (HBIO) — Dilution Risk Analysis
Current Snapshot
Harvard Bioscience, Inc. (HBIO) has a DilutionWatch score of 31/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 31/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
2 shelf registration or ATM offering filings detected in recent history.
Recent filing forms in the source payload: 4 5, 424B3 1, EFFECT 1, S-3 1, XBRL 1, 3 1.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-03-23 | 0001171843-26-001843 |
| 4 | 2026-03-18 | 0001171843-26-001689 |
| 4 | 2026-03-18 | 0001171843-26-001732 |
| 4 | 2026-03-17 | 0001171843-26-001645 |
| 424B3 | 2026-02-09 | 0001171843-26-000702 |
| EFFECT | 2026-02-09 | 9999999995-26-000490 |
| S-3 | 2026-01-30 | 0001171843-26-000539 |
| xbrl | 2025-12-31 | xbrl-6408-xbrl_warrant |
| 3 | 2025-12-30 | 0001171843-25-008126 |
| 4 | 2025-12-30 | 0001171843-25-008127 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Shelf registration capacity | $7,500,000 | Source |
| Cash runway | 999 months | Source |
| Three-year share count growth | -14.69% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 31/10) Source
- Cash Runway
- 999 months Source
- Shelf Registration Capacity
- $7,500,000 Source
- Share Count Growth (3-Year)
- -14.69% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.